Women with biopsy-proven breast cancer were randomized to receive either propofol general anaesthesia with paravertebral analgesia ( PPA ) or standard sevoflurane general anaesthesia with opioid analgesia ( SGA ) in an ongoing , prospective clinical trial ( NCT 00418457 ) .